Medical Store Opening Made Easy In UP

Lucknow:  While granting a license to open a pharmaceutical company and sell medicines, entrepreneurs will no longer be subjected to rules like size of the firm, investment, domestic or foreign investor and business risk like other businesses.

Due to its inclusion in Invest UP’s Business Reform Action Plan (BRAP)-2024, entrepreneurs are facing difficulties in getting licenses. In such a situation, the Food Safety and Drug Administration Department has written a letter demanding exemption from this.

While granting license for setting up a pharmaceutical company or for sale of medicines under the Drug and Cosmetic Act, only the storage capacity as per standards, facility to keep medicines at low temperature and registration of pharmacist are considered.

According to BRAP-2024 of Invest UP, the Food Safety and Drug Administration Department has already made arrangements for granting and monitoring licenses through an online portal. There is also a system to deposit fees online for the license and to see with which officer the file is pending or everything online.

In such a situation, Principal Secretary, Food Safety and Drug Administration P. Guruprasad sent a letter to the Chief Executive Officer of Invest UP demanding exemption from rules like size of firm etc. under BRAP, because there is no provision for this in the Drug and Cosmetic Act, hence it cannot be implemented. At present, after getting the exemption, the drug entrepreneurs will get a lot of relief.

Related Posts

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India